SI2197900T1 - Mutantni dvojno ciklizirani receptorski peptidi ki inhibirajo protitelesa beta adrenoceptorja - Google Patents
Mutantni dvojno ciklizirani receptorski peptidi ki inhibirajo protitelesa beta adrenoceptorjaInfo
- Publication number
- SI2197900T1 SI2197900T1 SI200830783T SI200830783T SI2197900T1 SI 2197900 T1 SI2197900 T1 SI 2197900T1 SI 200830783 T SI200830783 T SI 200830783T SI 200830783 T SI200830783 T SI 200830783T SI 2197900 T1 SI2197900 T1 SI 2197900T1
- Authority
- SI
- Slovenia
- Prior art keywords
- receptor peptides
- inhibiting beta
- peptides inhibiting
- mutant double
- cyclized
- Prior art date
Links
- 102000014992 beta1-adrenergic receptor activity proteins Human genes 0.000 title 1
- 108040006808 beta1-adrenergic receptor activity proteins Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07016637 | 2007-08-24 | ||
| PCT/EP2008/006932 WO2009027063A2 (en) | 2007-08-24 | 2008-08-22 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES |
| EP08801676A EP2197900B9 (en) | 2007-08-24 | 2008-08-22 | Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2197900T1 true SI2197900T1 (sl) | 2012-11-30 |
Family
ID=40130559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200830783T SI2197900T1 (sl) | 2007-08-24 | 2008-08-22 | Mutantni dvojno ciklizirani receptorski peptidi ki inhibirajo protitelesa beta adrenoceptorja |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9062095B2 (enExample) |
| EP (3) | EP2497777A3 (enExample) |
| JP (3) | JP5248610B2 (enExample) |
| CN (2) | CN103992406A (enExample) |
| AU (1) | AU2008291296B2 (enExample) |
| CA (1) | CA2697108C (enExample) |
| DK (1) | DK2197900T3 (enExample) |
| ES (1) | ES2391358T3 (enExample) |
| HR (1) | HRP20120827T1 (enExample) |
| PL (1) | PL2197900T3 (enExample) |
| PT (1) | PT2197900E (enExample) |
| SI (1) | SI2197900T1 (enExample) |
| WO (1) | WO2009027063A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103992406A (zh) * | 2007-08-24 | 2014-08-20 | 乌利班-马克西姆利安大学 | 抑制β1-肾上腺素受体抗体的突变双环化受体肽 |
| WO2010086337A1 (en) * | 2009-01-27 | 2010-08-05 | Julius-Maximilians-Universität Würzburg | Novel peptide-homologues for inhibiting beta1-adrenoceptor antibodies |
| DE102010018878B4 (de) | 2009-04-30 | 2013-09-26 | Julius-Maximilians-Universität Würzburg | Neue Zell-Linie zur Fluoreszenz-basierten Detektion von funktionell aktiven Antikörpern und Autoantikörpern gegen den Beta1-adrenergen Rezeptor |
| EP2402016A1 (en) * | 2010-06-29 | 2012-01-04 | Charité - Universitätsmedizin Berlin | Aptamers that inhibit interaction between antibody and 1st or 2nd extracellular loop of human beta-1-adrenergic receptor |
| WO2012168344A1 (en) | 2011-06-10 | 2012-12-13 | Corimmun Gmbh | BINDING COMPOUNDS TO HUMAN β1-ADRENORECEPTOR (β1-AR) AND THEIR USE IN THE MEASUREMENT OF AUTO-ANTI-βA1-AR ANTIBODIES |
| JP6170077B2 (ja) | 2012-02-16 | 2017-07-26 | エータイアー ファーマ， インコーポレイテッド | 自己免疫および炎症疾患を処置するためのヒスチジルｔＲＮＡ合成酵素 |
| CN105378075B (zh) | 2013-03-15 | 2022-04-05 | Atyr 医药公司 | 组氨酰-trna合成酶-fc缀合物 |
| JPWO2015022953A1 (ja) * | 2013-08-14 | 2017-03-02 | 国立大学法人 長崎大学 | 血液脳関門障害改善剤 |
| JP7679175B2 (ja) | 2017-04-20 | 2025-05-19 | エータイアー ファーマ， インコーポレイテッド | 肺の炎症を治療するための組成物および方法 |
| CN108218963B (zh) * | 2018-01-19 | 2020-10-13 | 首都医科大学 | 一种环肽及其制备方法和用途 |
| AU2020236015B9 (en) * | 2019-03-14 | 2024-11-28 | Genentech, Inc. | Treatment of cancer with HER2XCD3 bispecific antibodies in combination with anti-HER2 MAB |
| EP3715374A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the sequestration of undesirable antibodies in a patient |
| US11986536B2 (en) | 2019-03-23 | 2024-05-21 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
| WO2022063882A1 (en) * | 2020-09-23 | 2022-03-31 | Ablevia Biotech Gmbh | Compound for the prevention or treatment of autoantibody-mediated conditions |
| CN112266330B (zh) * | 2020-10-15 | 2023-02-24 | 长沙博源医疗科技有限公司 | 一种甲氧基肾上腺素衍生物、免疫原、抗甲氧基肾上腺素特异性抗体及其制备方法与应用 |
| WO2023028590A1 (en) * | 2021-08-27 | 2023-03-02 | Yale University | Molecular degraders of extracellular proteins |
| JP2023117892A (ja) * | 2022-02-14 | 2023-08-24 | 公益財団法人 鷹揚郷 | ヘプシジン結合ペプチド |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4711955A (en) | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
| CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US5792608A (en) | 1991-12-12 | 1998-08-11 | Gilead Sciences, Inc. | Nuclease stable and binding competent oligomers and methods for their use |
| US5525711A (en) | 1994-05-18 | 1996-06-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pteridine nucleotide analogs as fluorescent DNA probes |
| WO2001021660A1 (de) | 1999-09-21 | 2001-03-29 | Affina Immuntechnik Gmbh | Peptide gegen dcm hervorrufende autoantikörper |
| EP1225921A1 (en) * | 1999-11-05 | 2002-07-31 | The Regents of the University of California | TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| US20040001827A1 (en) * | 2002-06-28 | 2004-01-01 | Dennis Mark S. | Serum albumin binding peptides for tumor targeting |
| JP4541490B2 (ja) * | 2000-04-07 | 2010-09-08 | 株式会社カネカ | 拡張型心筋症用吸着体 |
| WO2001083693A2 (en) * | 2000-04-28 | 2001-11-08 | Glaxo Group Limited | Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses |
| CN1988914A (zh) * | 2001-08-23 | 2007-06-27 | 西兰制药公司 | 胞间通讯易化化合物的新医学用途 |
| CA2479750A1 (en) * | 2002-03-26 | 2003-10-09 | Dyax Corp. | Fibrinogen binding moieties |
| US20080206264A1 (en) * | 2003-02-04 | 2008-08-28 | New York University | Constrained Hiv V3 Loop Peptides as Novel Immunogens and Receptor Antagonists |
| EP1536020A1 (en) | 2003-11-26 | 2005-06-01 | Bayerische Julius-Maximilians-Universität Würzburg | Means and methods for optical determination of cAMP in vitro and in vivo |
| AU2006228664B2 (en) | 2005-03-31 | 2012-11-01 | Julius-Maximilians-Universitat Wurzburg | Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| CN103992406A (zh) * | 2007-08-24 | 2014-08-20 | 乌利班-马克西姆利安大学 | 抑制β1-肾上腺素受体抗体的突变双环化受体肽 |
-
2008
- 2008-08-22 CN CN201410108364.1A patent/CN103992406A/zh active Pending
- 2008-08-22 EP EP12170992A patent/EP2497777A3/en not_active Withdrawn
- 2008-08-22 CN CN200880112623.0A patent/CN101835793B/zh not_active Expired - Fee Related
- 2008-08-22 EP EP08801676A patent/EP2197900B9/en active Active
- 2008-08-22 CA CA2697108A patent/CA2697108C/en active Active
- 2008-08-22 US US12/733,347 patent/US9062095B2/en not_active Expired - Fee Related
- 2008-08-22 PT PT08801676T patent/PT2197900E/pt unknown
- 2008-08-22 DK DK08801676.1T patent/DK2197900T3/da active
- 2008-08-22 AU AU2008291296A patent/AU2008291296B2/en not_active Ceased
- 2008-08-22 SI SI200830783T patent/SI2197900T1/sl unknown
- 2008-08-22 HR HRP20120827AT patent/HRP20120827T1/hr unknown
- 2008-08-22 ES ES08801676T patent/ES2391358T3/es active Active
- 2008-08-22 PL PL08801676T patent/PL2197900T3/pl unknown
- 2008-08-22 JP JP2010521365A patent/JP5248610B2/ja not_active Expired - Fee Related
- 2008-08-22 EP EP12178671.9A patent/EP2559698B1/en not_active Not-in-force
- 2008-08-22 WO PCT/EP2008/006932 patent/WO2009027063A2/en not_active Ceased
-
2013
- 2013-03-08 JP JP2013046776A patent/JP2013176369A/ja active Pending
- 2013-03-08 JP JP2013046777A patent/JP2013138679A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9062095B2 (en) | 2015-06-23 |
| JP2013138679A (ja) | 2013-07-18 |
| AU2008291296B2 (en) | 2014-02-06 |
| JP2013176369A (ja) | 2013-09-09 |
| EP2197900B1 (en) | 2012-08-01 |
| EP2559698A3 (en) | 2013-03-06 |
| JP5248610B2 (ja) | 2013-07-31 |
| EP2197900B9 (en) | 2013-01-09 |
| US20100209445A1 (en) | 2010-08-19 |
| PL2197900T3 (pl) | 2012-12-31 |
| CA2697108A1 (en) | 2009-03-05 |
| EP2497777A3 (en) | 2012-10-10 |
| ES2391358T3 (es) | 2012-11-23 |
| CN101835793A (zh) | 2010-09-15 |
| CN101835793B (zh) | 2014-04-23 |
| CA2697108C (en) | 2018-05-22 |
| HRP20120827T1 (hr) | 2012-11-30 |
| EP2559698A2 (en) | 2013-02-20 |
| PT2197900E (pt) | 2012-10-24 |
| WO2009027063A3 (en) | 2009-07-23 |
| EP2497777A2 (en) | 2012-09-12 |
| DK2197900T3 (da) | 2012-10-22 |
| AU2008291296A1 (en) | 2009-03-05 |
| JP2010536356A (ja) | 2010-12-02 |
| CN103992406A (zh) | 2014-08-20 |
| WO2009027063A2 (en) | 2009-03-05 |
| EP2559698B1 (en) | 2014-11-12 |
| HK1176363A1 (en) | 2013-07-26 |
| EP2197900A2 (en) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2197900T1 (sl) | Mutantni dvojno ciklizirani receptorski peptidi ki inhibirajo protitelesa beta adrenoceptorja | |
| EP2184278A4 (en) | P2X4 RECEIVER ANTAGONIST | |
| PT1981902E (pt) | Antagonistas dos recetores nogo | |
| IL204536A0 (en) | Anti - il -6 receptor antibody | |
| EP2058304A4 (en) | P2X4 RECEPTOR ANTAGONIST | |
| ZA201001874B (en) | Nmda receptor antagonists for neuroprotection | |
| EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
| ZA201001597B (en) | Octahydropentalene compounds as chemokine receptor antagonists | |
| EP2129654A4 (en) | NEW ANTAGONISTS OF THE GLUCAGON RECEPTOR | |
| IL212551A0 (en) | Cxcr4 receptor compounds | |
| IL198650A0 (en) | Progesterone receptor antagonists | |
| IL187424A0 (en) | C5a RECEPTOR ANTAGONISTS | |
| IL205356A0 (en) | Novel glucocorticoid receptor agonists | |
| IL198241A0 (en) | Pyrazoline compounds as mineralocorticoid receptor antagonists | |
| IL184278A0 (en) | C5a RECEPTOR ANTAGONISTS | |
| ZA201000676B (en) | Pyrrolidine aryl-ether as NK3 receptor antagonists | |
| ZA201001125B (en) | Pyrrolidine Aryl-Ether as NK3 receptor antagonists | |
| EP2191830A4 (en) | SOLID PREPARATION COMPRISING A NPYY5 RECEPTOR ANTAGONIST | |
| IL198542A0 (en) | 2-aminoquinolines as 5-ht(5a)receptor antagonists | |
| EP2153736A4 (en) | NEW LEUKOTRIEN RECEPTOR ANTAGONIST | |
| IL200380A0 (en) | Mineralcorticoid receptor antagonists for the treatment of endometriosis | |
| ZA200903499B (en) | Indoles which act as via receptor antagonists | |
| EP2478001A4 (en) | BENEFICIAL PEPTIDE COMPOUNDS OF MU OPIACEOUS RECEPTOR | |
| EP2229400A4 (en) | ADVANTAGEOUS SALTS OF MU-OPIOD RECEPTOR PEPTIDES | |
| IL202454A0 (en) | Urotensin ii receptor antagonists |